Retracted] Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.

Abstract

Following the publication of the above article, a concerned reader has drawn to the Editor's attention that there were a number of apparently overlapping data panels shown in Fig.4C andD on p.2360 such that the data would have drawn from a smaller number of original sources, where the data panels were intended to show the results from differently performed experiments. Moreover, certain of the data shown in Figs.2D, 3B, C and E and 4F contained data that were strikingly similar to data that have appeared in other publications written by different authors at different research institutes. In view of the substantial number of overlapping data panels identified in Fig.4C and D, and the fact that certain of the data in the above article have appeared in other published articles, the Editor of International Journal of Oncology has decided that this paper should be retracted from the publication on account of a lack of confidence in the presented data. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Oncology 46: 2355‑2363, 2015; DOI: 10.3892/ijo.2015.2959].